BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 26193780)

  • 1. Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: Outcomes of patients admitted to intensive care unit.
    Mokart D; Granata A; Crocchiolo R; Sannini A; Chow-Chine L; Brun JP; Bisbal M; Faucher M; Faucher C; Blache JL; Castagna L; Fürst S; Blaise D
    J Crit Care; 2015 Oct; 30(5):1107-13. PubMed ID: 26193780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors of non-invasive ventilation failure in hematopoietic stem-cell transplantation patients with acute respiratory distress syndrome.
    Shen J; Hu Y; Zhao H; Xiao Z; Zhao L; Du A; An Y
    Ther Adv Respir Dis; 2020; 14():1753466620914220. PubMed ID: 32345137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study.
    Bird GT; Farquhar-Smith P; Wigmore T; Potter M; Gruber PC
    Br J Anaesth; 2012 Mar; 108(3):452-9. PubMed ID: 22298243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
    Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
    Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and long-term outcomes in onco-hematological patients admitted to the intensive care unit with classic factors of poor prognosis.
    Faucher E; Cour M; Jahandiez V; Grateau A; Baudry T; Hernu R; Simon M; Robert JM; Michallet M; Argaud L
    Oncotarget; 2016 Apr; 7(16):22427-38. PubMed ID: 26968953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients.
    Lueck C; Stadler M; Koenecke C; Hoeper MM; Dammann E; Schneider A; Kielstein JT; Ganser A; Eder M; Beutel G
    Intensive Care Med; 2018 Sep; 44(9):1483-1492. PubMed ID: 30141173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.
    Goker H; Ozdemir E; Uz B; Buyukasik Y; Turgut M; Serefhanoglu S; Aksu S; Sayinalp N; Haznedaroglu IC; Tekin F; Karacan Y; Unal S; Eliacik E; Isik A; Ozcebe OI
    Transfus Apher Sci; 2013 Dec; 49(3):590-9. PubMed ID: 23981652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports.
    Pène F; Aubron C; Azoulay E; Blot F; Thiéry G; Raynard B; Schlemmer B; Nitenberg G; Buzyn A; Arnaud P; Socié G; Mira JP
    J Clin Oncol; 2006 Feb; 24(4):643-9. PubMed ID: 16380411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning.
    Townsend WM; Holroyd A; Pearce R; Mackinnon S; Naik P; Goldstone AH; Linch DC; Peggs KS; Thomson KJ; Singer M; Howell DC; Morris EC
    Br J Haematol; 2013 May; 161(4):578-86. PubMed ID: 23496350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term outcomes of adult allogeneic hematopoietic stem cell transplant patients admitted to the intensive care unit in the peritransplant period.
    Mayer S; Pastores SM; Riedel E; Maloy M; Jakubowski AA
    Leuk Lymphoma; 2017 Feb; 58(2):382-390. PubMed ID: 27347608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of allogeneic hematopoietic stem cell transplant recipients admitted to the intensive care unit with a focus on haploidentical graft and sequential conditioning regimen: results of a retrospective study.
    Gournay V; Dumas G; Lavillegrand JR; Hariri G; Urbina T; Baudel JL; Ait-Oufella H; Maury E; Brissot E; Legrand O; Malard F; Mohty M; Guidet B; Duléry R; Bigé N
    Ann Hematol; 2021 Nov; 100(11):2787-2797. PubMed ID: 34476574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of noninvasive ventilation in acute respiratory failure in critically ill patients: a prospective, observational, cohort study.
    Corrêa TD; Sanches PR; de Morais LC; Scarin FC; Silva E; Barbas CS
    BMC Pulm Med; 2015 Nov; 15():144. PubMed ID: 26559350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes in patients treated in the intensive care unit after hematopoietic stem cell transplantation.
    Nakamura M; Fujii N; Shimizu K; Ikegawa S; Seike K; Inomata T; Sando Y; Fujii K; Nishimori H; Matsuoka KI; Morimatsu H; Maeda Y
    Int J Hematol; 2018 Dec; 108(6):622-629. PubMed ID: 30238198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic stem cell transplantation recipients requiring intensive care: time is of the essence.
    Orvain C; Beloncle F; Hamel JF; Del Galy AS; Thépot S; Mercier M; Kouatchet A; Farhi J; Francois S; Ifrah N; Mercat A; Asfar P; Hunault-Berger M; Tanguy-Schmidt A
    Ann Hematol; 2018 Sep; 97(9):1601-1609. PubMed ID: 29717367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for noninvasive ventilation failure in cancer patients in the intensive care unit: A retrospective cohort study.
    Ferreira JC; Medeiros P; Rego FM; Caruso P
    J Crit Care; 2015 Oct; 30(5):1003-7. PubMed ID: 26072388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of Allogeneic Haematopoietic Stem Cell Recipients Admitted to the Intensive Care Unit: A Retrospective, Single-Centre Study.
    Lindgaard SC; Nielsen J; Lindmark A; Sengeløv H
    Acta Haematol; 2016; 135(2):72-8. PubMed ID: 26512978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients.
    Afessa B; Tefferi A; Dunn WF; Litzow MR; Peters SG
    Crit Care Med; 2003 Jun; 31(6):1715-21. PubMed ID: 12794410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intensive care management process in patients with hematopoietic stem cell transplantation and factors affecting their prognosis.
    Boyacı N; Aygencel G; Turkoglu M; Yegin ZA; Acar K; Sucak GT
    Hematology; 2014 Sep; 19(6):338-45. PubMed ID: 24620953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma.
    Kekre N; Marquez-Malaver FJ; Cabrero M; Piñana J; Esquirol A; Soiffer RJ; Caballero D; Terol MJ; Martino R; Antin JH; Lopez-Corral L; Solano C; Armand P; Pérez-Simon JA
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1808-1815. PubMed ID: 27470290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for Noninvasive Ventilation Failure in Critically Ill Subjects With Confirmed Influenza Infection.
    Rodríguez A; Ferri C; Martin-Loeches I; Díaz E; Masclans JR; Gordo F; Sole-Violán J; Bodí M; Avilés-Jurado FX; Trefler S; Magret M; Moreno G; Reyes LF; Marin-Corral J; Yebenes JC; Esteban A; Anzueto A; Aliberti S; Restrepo MI; ;
    Respir Care; 2017 Oct; 62(10):1307-1315. PubMed ID: 28698265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.